Biomarkers of inflammation in children with tuberculosis
Abstract
The aim of this study was to evaluate the efficacy of using appropriate biomarkers of inflammation for diagnosis of tuberculosis in children, monitoring the disease and the effects of the applied therapy.
Material and methods: In this study, 60 patients were included and divided into two groups: control group of 40 healthy children and a group of 20 children with tuberculosis. The subjects from both groups were aged from 1 to 15 years, matched by age. The children with tuberculosis were hospitalized for diagnostic and therapeutic treatment. None of them received corticosteroid therapy before treatment. Blood samples from patients with tuberculosis were taken just before the therapy and after 2 months. The concentration of three biomarkers close-related with the evolution of the disease was analyzed in blood sera: tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP) and procalcitonin (PCT). Serum concentrations of TNF-a were measured in vitro using IMMULITE 1000 analyzer for quantitative measurement of TNF-α in serum (EIA). Determination of CRP and PCT in serum was done with the quantitative method (ELFA) using i-CHROMA - immune analyzer.
Results: A statistically significant difference was found in the concentrations of TNFa serum before and after treatment (18.54 ± 1.94 v.s. 10.02± 0.640 pg/ml, p<0.05), СRP before and after therapy (99.59 ± 9.23 v.s 9.13 ± 1.13 mg/L, p<0.05), and РСТ (0.31 ± 0.02 v.s. 0.04 ± 0,01 ng/ml, p<0.05).
Conclusion: The results showed that tested biomarkers of inflammation are important for early diagnosis and monitoring the effects of the anti-tuberculosis therapy.Downloads
References
World Health Organization. Global Tuberculosis Control:
Surveillance, Planning, Financing. Geneva: World
Health Organization; 2002.
Casarini M, Aneglio F, Alemanno L. Cytokine levels correlate
with a Radiologic Score in Active Pulmonary Tuberculosis.
Am J Respir Crit Care Med. 1999; 159: 143-148.
American Thoracic Society. Diagnostic Standard and
Classification of Tuberculosis in Adult and Children.
Am Respir Crit Care Med. 2000; 161:1376-1395.
Andersen P, Munk ME, Doherty TM, еt al. Specific immune-
based diagnosis of tuberculosis. Lancet. 2000;
:1099-104.
Alatas F, Alatas O, Metintas M. The rule of IL-12, IL-
, TNFa, IFN- gama and TGF- betaA1 in pulmonary
tuberculosis. Turkish Thoracic Society. 2002; 3
(Suppl. 1):20-23
Toossi Z. The inflammatory response in Mycobacterium
tuberculosis infection. Arch Immunol Ther Exp.
; 48(6): 513-9.
Gerbeaux J. Tuberculose primaire de L enfant. Rev Tuberc.
; 35:315.
WHO. Global tuberculosis control:Survillance, Planning,
Financing. Genova : World Health Organization;
Roach DR, Briscoe H. Tumor necrosis factor (TNF)
and a TNF-mimetic peptide modulate the granulomatous
response to Mycobacterium bovis BCG infection
in vivo. Infect Immun. 1999; 67(10): 5473-6.
Che L, Lu J. Meаsurement of serum tumor necrosis
factor-alfa and interleukin-8 in children with low respiratory
tract infection (LRTI) caused by Mycoplazma
pneumonia. ECACI. 1999; (1): 50-2.
Comstock G. The International Tuberculosis Campaign:
a pioneering venture in mass vaccination and research.
Clin Infect Dis. 1994. 19 (3): 528–540.
Marais BJ, Gie RP, Hesseling AC, et al. A refined symptom-
based approach to diagnose pulmonary tuberculosis
in children. Pediatrics. 2006; 118:1350-9.
Marais BJ, Pai M. Recent advances in the diagnosis of
childhood tuberculosis. Arch Dis Child. 2007; 92: 446-52.
Kapotis C, Samara E. Determination of IL-4, IL-6, IL-8
interleukins and TNF a in patients with tuberculosis
during treatment. DMBS. 2003; (Suppl 2) : 22-23 .
Knoring VE, Simbertsev AS. Changes in the production
of interleukin-1beta, tumor necrosis factor- alfa
and interleukin-2 in relation to the immunity
in patients with pulmonary tuberculosis. Probl Tuberk.
; 4: 31-5.
Beutler B, Krochin N. Control of cachectin/tumor necrosis
factor. Science. 1986; 232: 977- 80.
Schlag G, Redl H. Mediators of Injury and inflammation.
World J Surg. 1996; 20: 406- 410
Schiffman G. Tuberculosis Symptoms. Medicine Health;
Gerbeaux J, Hanoteau J. Medications recentes dans le
traiment de la tuberculose primaire. Rev Tuberc.
; 35:315
Lebel H.M, Bishara J. Dexamethasone therapy for bacterial
meningitis. N Engl J Med. 1988; 319: 964-71.
Lambert H. The Chemioprophylaxis of Tuberculosis.
Amer Rev Resp Dis. 1959; 80:648
Keane J, Gershon S, Wise RP. Tuberculosis associated
with infliximab, a tumor necrosis factor alfa-neutralizing
agent. N Engl J Med. 2001; 345(15):1098-104.
Mitrevski A. Using protein as a marker for inflammation
and sepsis. Mac.Med.Review. 2005; 12: 25-26.
National Institute for Health and Clinical Excellence.
Tuberculosis: Clinical Diagnosis and Management of
Tuberculosis and Measures for Its Prevention and
Control.Clinical guideline 117. 2011.
Barnes FP, Fong SJ, Brennan JP. Local production
of tumor necrosis factor and IFN-g in tuberculous
pleuritis. The Journal of Immunology. 1990;145:
- 154.
Casarini M, Aneglio F, Alemanno L. Cytokine levels
correlate with a radiologic score in active pulmonary
tuberculosis. Am J Respir Crit Care Med. 1999; 159:
-148
Pivet A, Chedevergne FM. Cytokine transcripts in pediatric
tuberculosis: a study with bronchoalveolar
cells. Tuber Lung Dis. 2000; 80(6): 249-58.
Sester M et al. Interferon-� release assays for the diagnosis
of active tuberculosis: a systematic review and
meta-analysis. The European Respiratory Journal.
; 37: 100–11.
Johnston W, Saltzman H, Bufkin J, Smith D. The Tuberculin
Test and the Diagnosis of Clinical Tuberculosis.
Amer Rev Resp Dis. 1960; 81: 189.
Wilson CB, Lewis DB. Basis and implications of selectively
diminished cytokine production in neonatal
susceptibility to infection. Rev Infect Dis.
;12: 410-20.
Al-Nawas B. Krammer I. Shah PM. Procalcitonin in
diagnosis of severe infections. Bur J Med Res. 1996;
(7): 331-3.
Atanasova V. Rosmanova R. Andreeva H. Procalcitonin:
an inovative marker for bacterial infections.Biochemical,
immunologieal and clinical aspects. Clin
AppI Immunol Invest. 2001; 1: 153-60.
Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011; 378:
–72.
Ahmed N, Hasnain S. Molecular epidemiology of tuberculosis
in India: Moving forward with a systems
biology approach. Tuberculosis. 2011; 91: 407–413.
Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis
in children. Lancet Infect Dis. 2003; 3: 624-31.
Vol.7 No.1 2015
Downloads
Published
How to Cite
Issue
Section
License
All wrights are reserved.


